Posterior reversible encephalopathy syndrome due to targeted agents: vemurafinib among suspects!
- Published in:
- Journal of Oncology Pharmacy Practice, 2015, v. 21, n. 6, p. 443, doi. 10.1177/1078155214543212
- By:
- Publication type:
- Article
Works matching IS 10781552 AND DT 2015 AND VI 21 AND IP 6
Results: 11
1
2
Delayed hypersensitivity reaction related to the use of pegfilgrastim.
- Published in:
- Journal of Oncology Pharmacy Practice, 2015, v. 21, n. 6, p. 474, doi. 10.1177/1078155214542493
- By:
- Publication type:
- Article
3
Pyoderma gangrenosum due to lenalidomide use for multiple myeloma.
- Published in:
- Journal of Oncology Pharmacy Practice, 2015, v. 21, n. 6, p. 471, doi. 10.1177/1078155214541975
- By:
- Publication type:
- Article
4
A phase I study to determine the maximum tolerated dose and safety of oral LR-103 (1α,24(S)Dihydroxyvitamin D<sub>2</sub>) in patients with advanced cancer.
- Published in:
- Journal of Oncology Pharmacy Practice, 2015, v. 21, n. 6, p. 416, doi. 10.1177/1078155214541572
- By:
- Publication type:
- Article
5
Busulfan dosing (Q6 or Q24) with adjusted or actual body weight, does it matter?
- Published in:
- Journal of Oncology Pharmacy Practice, 2015, v. 21, n. 6, p. 425, doi. 10.1177/1078155214541571
- By:
- Publication type:
- Article
6
Targeting the mammalian target of rapamycin pathway with everolimus: Implications for the management of metastatic breast cancer.
- Published in:
- Journal of Oncology Pharmacy Practice, 2015, v. 21, n. 6, p. 433, doi. 10.1177/1078155214540732
- By:
- Publication type:
- Article
7
Dosing algorithm for concomitant administration of sirolimus, tacrolimus, and an azole after allogeneic hematopoietic stem cell transplantation.
- Published in:
- Journal of Oncology Pharmacy Practice, 2015, v. 21, n. 6, p. 409, doi. 10.1177/1078155214539825
- By:
- Publication type:
- Article
8
Is there any cumulative dose for trastuzumab?
- Published in:
- Journal of Oncology Pharmacy Practice, 2015, v. 21, n. 6, p. 468, doi. 10.1177/1078155214538686
- By:
- Publication type:
- Article
9
Clinical evaluation of compounds targeting PD-1/PD-L1 pathway for cancer immunotherapy.
- Published in:
- Journal of Oncology Pharmacy Practice, 2015, v. 21, n. 6, p. 451, doi. 10.1177/1078155214538087
- By:
- Publication type:
- Article
10
Adherence to imatinib among patients attending Saskatchewan Cancer Agency Pharmacies.
- Published in:
- Journal of Oncology Pharmacy Practice, 2015, v. 21, n. 6, p. 403, doi. 10.1177/1078155214537926
- By:
- Publication type:
- Article
11
Practical considerations in the use of intravenous tacrolimus in hematopoietic stem cell transplantation patients.
- Published in:
- Journal of Oncology Pharmacy Practice, 2015, v. 21, n. 6, p. 478, doi. 10.1177/1078155214531609
- By:
- Publication type:
- Article